News | October 04, 2021
Pfizer transfers certain medicines to Mylan as part of an agreement
The consideration for the medicines in India is valued at Rs 180.48 crore
The consideration for the medicines in India is valued at Rs 180.48 crore
Adjusted PAT declined 18.8% YoY
Subscribe To Our Newsletter & Stay Updated